Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00YOV
|
|||
| Former ID |
DIB003741
|
|||
| Drug Name |
MT-110
|
|||
| Synonyms |
MuS110; Bispecific EpCAM/CD3 antibody (cancer), Micromet
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Micromet AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells. Clin Cancer Res. 2012 Jan 15;18(2):465-74. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.